• Company
  • Team
  • Portfolio
  • Global
company
  • Overview
  • Message from the CEO
  • History
  • ESG management
  • Affiliates
  • Investment Fund
  • Investor Network
  • News
  • SBI Brand
team
  • Management
  • Venture Investment
    DivisionⅠ
  • Venture Investment
    Division Ⅱ
  • Venture Investment
    Division Ⅲ
  • Venture Investment
    Division Ⅳ
  • PE Division
  • Investment Portfolio
    Management Team
  • Compliance and
    Legal Department
  • Management
    Support Division
portfolio
  • Principal Portfolio
  • IPO Companies
oversea
  • SBI Holdings, Japan
  • SBI’s Overseas
    Affiliates
  • Business Plan Submisson
  • Korean
Copyrightⓒ2014
SBI Investment KOREA.
All right reserved.

EQUIPPED WITH 110
YEARS OF ACCUMULATIVE
EXPERIENCE.

  • SiHyoung Park
    SiHyoung ParkDirector / Head of Venture Investment Division IV at SBI Investment KOREA
    SiHyoung Park SiHyoung ParkDirector / Head of Venture Investment Division IV at SBI Investment KOREA
    Equity Analyst of Bio/Pharmaceuticals at CGS-CIMB Securities
    Equity Analyst of Bio/Pharmaceuticals at IBK Securities
  • TaeYoung Lee
    TaeYoung LeeTeam Manager / Venture Investment Division IV at SBI Investment KOREA
    TaeYoung Lee TaeYoung LeeTeam Manager / Venture Investment Division IV at SBI Investment KOREA
    KB Securities Senior Researcher of Pharmaceuticals/Bio
    Meritz Securities Senior Researcher on Pharmaceuticals/Bio
    MR. Korea Astellas Pharmaceutical Co., Ltd.
  • Sim Min Jung
    Sim Min JungManager / Venture Investment Division IV at SBI Investment Korea
    Sim Min Jung Sim Min JungManager / Venture Investment Division IV at SBI Investment Korea
    Medical Information specialist at Korea Otsuka Pharmaceutical
    Medical Science Liaison at Korea Otsuka Pharmlaceutical